secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2022-12-05T23:59:59+00:00
Accession:  0001193125-22-298535
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences raises $86.7M in public offering of 7.7M shares at $12.00/share
--------------------------------------------------------------------------------

- Net proceeds of ~$86.7M from 7.705M shares (including full overallotment) at $12.00 per share.
- Proceeds to advance belzupacap sarotalocan for choroidal melanoma and NMIBC, plus platform and corporate.
- Management expects cash runway to fund operations into 2025.
- Offering closed Dec 5, 2022; underwriters led by SVB Securities, Cowen, Evercore.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312522298535/0001193125-22-298535-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312522298535/d393902d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-298535

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer